Drawing for MNKD

USPTO serial 98423174

MNKD

Reviewed by CopyMark Law Group

Status 733Notice of Allowance
Filing date
Status date
Registration date
—
Examiner
BARQUET-HORNBACK, ELENA M
Law office
TMO LAW OFFICE 135

What this means

The USPTO has issued a Notice of Allowance. To complete registration you generally need to file a Statement of Use or an extension request before the deadline.

Status 733: Status 733 means the fourth six-month extension was granted. Only one extension typically remains before you must file a Statement of Use or risk abandonment.

Need help with MNKD?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Get help with this Notice of Allowance, set up monitoring, or talk with CopyMark.
Get Attorney Assistance for just $648*

Plus Government fees of $300

Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Jaclyne D. Wallace

Jaclyne D. Wallace Foley & Lardner LLP321 North Clark Street, Suite 3000Chicago, IL 60654United States

Goods and services

ClassDescriptionStatusFirst use
005Pharmaceutical preparations for the treatment of diabetes, endocrine diseases and disorders, metabolic diseases and disorders; Pharmaceutical preparations for inhalation for the treatment of lung diseases and disorders, including, pulmonary arterial hypertension and interstitial lung diseases, including, idiopathic pulmonary fibrosis, and lung infections, including, mycobacterial infectionsACTIVE—
010Medical devices, namely, devices for the administration of pharmaceuticals for inhalation for the treatment of lung diseases and disorders, including pulmonary arterial hypertension and interstitial lung diseases, including, idiopathic pulmonary fibrosis, and lung infections, including, mycobacterial infections; Medical devices, namely, devices for the administration of pharmaceuticals for the treatment of diabetes, endocrine diseases and disorders, metabolic diseases and disordersACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Nov 5, 2026EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Nov 4, 2026EX4GSOU EXTENSION 4 GRANTED—
Nov 4, 2026EXT4SOU EXTENSION 4 FILED—
Nov 4, 2026EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
May 22, 2026EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
May 21, 2026EX3GSOU EXTENSION 3 GRANTED—
May 21, 2026EXT3SOU EXTENSION 3 FILED—
May 21, 2026EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Oct 18, 2025EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Oct 17, 2025EX2GSOU EXTENSION 2 GRANTED—
Oct 17, 2025EXT2SOU EXTENSION 2 FILED—
Oct 17, 2025EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Sep 3, 2025ASCKASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY—
May 7, 2025EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
May 7, 2025EX1GSOU EXTENSION 1 GRANTED—
May 6, 2025EXT1SOU EXTENSION 1 FILED—
May 6, 2025EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Dec 3, 2024NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Oct 22, 2024NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Oct 22, 2024PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Oct 2, 2024NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Sep 16, 2024CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Sep 15, 2024DOCKASSIGNED TO EXAMINER—
Jul 8, 2024NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Feb 27, 2024NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance